{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:44:40Z","timestamp":1792413880288,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"DOI":"10.1038\/s41418-026-01883-7","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:09:54Z","timestamp":1792411794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The NEK8\/ALYREF axis promotes cisplatin resistance in bladder cancer by stabilizing CDK18 mRNA to facilitate DNA damage repair"],"prefix":"10.1038","author":[{"given":"Jia-Yin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7563-7781","authenticated-orcid":false,"given":"Zhi-Bin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Heng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6461-7435","authenticated-orcid":false,"given":"Xue-Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7426-6501","authenticated-orcid":false,"given":"Qing-Shui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-3733","authenticated-orcid":false,"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4396-5526","authenticated-orcid":false,"given":"Hai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-7025","authenticated-orcid":false,"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"1883_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1883_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, et al. Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol. 2022;5:628\u201339.","journal-title":"Eur Urol Oncol"},{"key":"1883_CR3","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"key":"1883_CR4","doi-asserted-by":"crossref","unstructured":"Groeneveld CS, Pfister C, Culine S, Harter V, Krucker C, Fontugne J, et al. Basal\/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial. Ann Oncol. 2024;36:89\u201398.","DOI":"10.1016\/j.annonc.2024.09.008"},{"key":"1883_CR5","doi-asserted-by":"crossref","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2023 Guidelines. Eur Urol. 2023;85:17\u201331.","DOI":"10.1016\/j.eururo.2023.08.016"},{"key":"1883_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100785","volume":"3","author":"J Hu","year":"2022","unstructured":"Hu J, Chen J, Ou Z, Chen H, Liu Z, Chen M, et al. Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study. Cell Rep Med. 2022;3:100785.","journal-title":"Cell Rep Med"},{"key":"1883_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.eururo.2020.08.024","volume":"79","author":"C Pfister","year":"2021","unstructured":"Pfister C, Gravis G, Fl\u00e9chon A, Souli\u00e9 M, Guy L, Laguerre B, et al. Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin, or gemcitabine and cisplatin as perioperative chemotherapy for patients with muscle-invasive bladder cancer. Analysis of the GETUG\/AFU V05 VESPER trial secondary endpoints: chemotherapy toxicity and pathological responses. Eur Urol. 2021;79:214\u201321.","journal-title":"Eur Urol"},{"key":"1883_CR8","doi-asserted-by":"crossref","unstructured":"Deng M, Zhou Z, Chen J, Li X, Liu Z, Ye J, et al. Enhanced oxidative phosphorylation driven by TACO1 mitochondrial translocation promotes stemness and cisplatin resistance in bladder cancer. Adv Sci. 2024;12:e2408599.","DOI":"10.1002\/advs.202408599"},{"key":"1883_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","volume":"44","author":"T Li","year":"2025","unstructured":"Li T, Zhu K, Tong H, Sun Y, Zhu J, Qin Z, et al. Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. J Exp Clin Cancer Res. 2025;44:265.","journal-title":"J Exp Clin Cancer Res"},{"key":"1883_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.","journal-title":"Drug Resist Updat"},{"key":"1883_CR11","doi-asserted-by":"crossref","unstructured":"Nguyen K, Boehling J, Tran MN, Cheng T, Rivera A, Collins-Burow BM, et al. NEK family review and correlations with patient survival outcomes in various cancer types. Cancers. 2023;15:2067.","DOI":"10.3390\/cancers15072067"},{"key":"1883_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10238-021-00782-0","volume":"23","author":"NK Panchal","year":"2023","unstructured":"Panchal NK, Evan Prince S. The NEK family of serine\/threonine kinases as a biomarker for cancer. Clin Exp Med. 2023;23:17\u201330.","journal-title":"Clin Exp Med"},{"key":"1883_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/15384101.2016.1259038","volume":"16","author":"A Abeyta","year":"2017","unstructured":"Abeyta A, Castella M, Jacquemont C, Taniguchi T. NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protection. Cell Cycle. 2017;16:335\u201347.","journal-title":"Cell Cycle"},{"key":"1883_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01215-z","volume":"21","author":"B Cao","year":"2023","unstructured":"Cao B, Zhang K, Pan C, Dong Y, Lu F. NEK8 regulates colorectal cancer progression via phosphorylating MYC. Cell Commun Signal. 2023;21:209.","journal-title":"Cell Commun Signal"},{"key":"1883_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32631-3","volume":"13","author":"E Kang","year":"2023","unstructured":"Kang E, Kim HK, Lee HB, Han W. Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via \u03b2-catenin signalling activation. Sci Rep. 2023;13:6829.","journal-title":"Sci Rep"},{"key":"1883_CR16","doi-asserted-by":"publisher","first-page":"8748","DOI":"10.1111\/jcmm.16831","volume":"25","author":"M Xiao","year":"2021","unstructured":"Xiao M, Du C, Zhang C, Zhang X, Li S, Zhang D, et al. Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in glioma. J Cell Mol Med. 2021;25:8748\u201363.","journal-title":"J Cell Mol Med"},{"key":"1883_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111827","volume":"41","author":"J Kang","year":"2022","unstructured":"Kang J, Chun J, Hwang JS, Pan C, Li J, Boese AC, et al. EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer. Cell Rep. 2022;41:111827.","journal-title":"Cell Rep"},{"key":"1883_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5088","volume":"5","author":"Q Miao","year":"2014","unstructured":"Miao Q, Ku AT, Nishino Y, Howard JM, Rao AS, Shaver TM, et al. Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2. Nat Commun. 2014;5:4088.","journal-title":"Nat Commun"},{"key":"1883_CR19","doi-asserted-by":"crossref","unstructured":"Zhao H, Lin N, Ho VWS, Liu K, Chen X, Wu H, et al. Patient-derived bladder cancer organoids as a valuable tool for understanding tumor biology and developing personalized treatment. Adv Sci. 2025;12:e2414558.","DOI":"10.1002\/advs.202414558"},{"key":"1883_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112796","volume":"42","author":"S Xu","year":"2023","unstructured":"Xu S, Suttapitugsakul S, Tong M, Wu R. Systematic analysis of the impact of phosphorylation and O-GlcNAcylation on protein subcellular localization. Cell Rep. 2023;42:112796.","journal-title":"Cell Rep"},{"key":"1883_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/cr.2017.55","volume":"27","author":"X Yang","year":"2017","unstructured":"Yang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, et al. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m5C reader. Cell Res. 2017;27:606\u201325.","journal-title":"Cell Res"},{"key":"1883_CR22","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.7150\/ijbs.126319","volume":"22","author":"ZB Ke","year":"2026","unstructured":"Ke ZB, Chen JY, Lin B, Chen CR, Xue YT, Sun JB, et al. OTUB2\/ALYREF axis modulates the docetaxel resistance of castration-resistant prostate cancer via upregulating ABCG4-mediated drug efflux. Int J Biol Sci. 2026;22:3342\u201366.","journal-title":"Int J Biol Sci"},{"key":"1883_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10993-5","volume":"10","author":"JF Ning","year":"2019","unstructured":"Ning JF, Stanciu M, Humphrey MR, Gorham J, Wakimoto H, Nishihara R, et al. Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma. Nat Commun. 2019;10:2910.","journal-title":"Nat Commun"},{"key":"1883_CR24","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1093\/nar\/gkw615","volume":"44","author":"G Barone","year":"2016","unstructured":"Barone G, Staples CJ, Ganesh A, Patterson KW, Bryne DP, Myers KN, et al. Human CDK18 promotes replication stress signaling and genome stability. Nucleic Acids Res. 2016;44:8772\u201385.","journal-title":"Nucleic Acids Res"},{"key":"1883_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10020-024-01062-9","volume":"31","author":"M Wang","year":"2025","unstructured":"Wang M, Yu K, Meng F, Wang H, Li Y. NEK8 promotes the progression of gastric cancer by reprogramming asparagine metabolism. Mol Med. 2025;31:3.","journal-title":"Mol Med"},{"key":"1883_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70203","volume":"15","author":"S Huang","year":"2025","unstructured":"Huang S, Shi D, Dai S, Jiang X, Wang R, Yang M, et al. RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancer. Clin Transl Med. 2025;15:e70203.","journal-title":"Clin Transl Med"},{"key":"1883_CR27","doi-asserted-by":"crossref","unstructured":"Jin T, Yang L, Chang C, Luo H, Wang R, Gan Y, et al. HnRNPA2B1 ISGylation regulates m6A-Tagged mRNA selective export via ALYREF\/NXF1 complex to foster breast cancer development. Adv Sci. 2024;11:e2307639.","DOI":"10.1002\/advs.202307639"},{"key":"1883_CR28","doi-asserted-by":"crossref","unstructured":"Yang S, He P, Wang W, Xu X, Xi X, Li Y Multi-omics analysis reveals that ALYREF-mediated m5C modification promotes platinum resistance in ovarian cancer via the NSUN2\/ALYREF\/LGR4 axis. Cell Death Dis. 2025;17:77.","DOI":"10.1038\/s41419-025-08310-8"},{"key":"1883_CR29","doi-asserted-by":"crossref","unstructured":"Hu J, Liu Q, Feng B, Lu Y, Chen K ALYREF-mediated regulation of TBL1XR1 and KMT2E synergistically upregulates APOC1, contributing to oxaliplatin resistance in esophageal cancer. Cancer Res Treat. 2025;57:1064\u201389.","DOI":"10.4143\/crt.2024.1091"},{"key":"1883_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cac2.12158","volume":"41","author":"JZ Wang","year":"2021","unstructured":"Wang JZ, Zhu W, Han J, Yang X, Zhou R, Lu HC, et al. The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. Cancer Commun. 2021;41:560\u201375.","journal-title":"Cancer Commun"},{"key":"1883_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02043-6","volume":"23","author":"J Karimbayli","year":"2024","unstructured":"Karimbayli J, Pellarin I, Belletti B, Baldassarre G. Insights into the structural and functional activities of forgotten Kinases: PCTAIREs CDKs. Mol Cancer. 2024;23:135.","journal-title":"Mol Cancer"},{"key":"1883_CR32","doi-asserted-by":"publisher","first-page":"10151","DOI":"10.1111\/jcmm.15625","volume":"24","author":"P Li","year":"2020","unstructured":"Li P, Ge D, Li P, Hu F, Chu J, Chen X, et al. CXXC finger protein 4 inhibits the CDK18-ERK1\/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1\/MIR100HG pathway. J Cell Mol Med. 2020;24:10151\u201365.","journal-title":"J Cell Mol Med"},{"key":"1883_CR33","doi-asserted-by":"crossref","unstructured":"F\u00f6rsti A, Ambrozkiewicz F, Marciniak M, Lubinski J, Hemminki K. Search for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers. Int J Cancer. 2024;156:1393\u20131403.","DOI":"10.1002\/ijc.35283"},{"key":"1883_CR34","doi-asserted-by":"publisher","first-page":"29508","DOI":"10.18632\/oncotarget.25686","volume":"9","author":"G Barone","year":"2018","unstructured":"Barone G, Arora A, Ganesh A, Abdel-Fatah T, Moseley P, Ali R, et al. The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response. Oncotarget. 2018;9:29508\u201324.","journal-title":"Oncotarget"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01883-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:09:56Z","timestamp":1792411796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01883-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":34,"alternative-id":["1883"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01883-7","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Experimental Animal Ethics Committee of Fujian Medical University. All experiments were performed according to the written confirmation that this study was in accordance with relevant institutional guidelines and regulations of Fujian Medical University and national guidelines and regulations of China.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent for publication of the manuscript was obtained from all authors.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}